Literature DB >> 10986966

Pancreatic cancer: state-of-the-art care.

K D Lillemoe1, C J Yeo, J L Cameron.   

Abstract

This review focuses on the pathogenesis, diagnosis, staging, and treatment of pancreatic cancer. Although much is needed to improve the still dismal outlook for patients with this disease, significant progress has been made in its surgical and oncologic management. Furthermore, our deepening understanding of the molecular genetics of pancreatic cancer lends hope for the possibility of earlier detection, which would result in substantial improvements in survival.

Entities:  

Mesh:

Year:  2000        PMID: 10986966     DOI: 10.3322/canjclin.50.4.241

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  39 in total

Review 1.  A systematic review and meta-analysis of pylorus-preserving versus classical pancreaticoduodenectomy for surgical treatment of periampullary and pancreatic carcinoma.

Authors:  Markus K Diener; Hanns-Peter Knaebel; Christina Heukaufer; Gerd Antes; Markus W Büchler; Christoph M Seiler
Journal:  Ann Surg       Date:  2007-02       Impact factor: 12.969

2.  Advances in counselling and surveillance of patients at risk for pancreatic cancer.

Authors:  Randall E Brand; Markus M Lerch; Wendy S Rubinstein; John P Neoptolemos; David C Whitcomb; Ralph H Hruban; Teresa A Brentnall; Henry T Lynch; Marcia I Canto
Journal:  Gut       Date:  2007-10       Impact factor: 23.059

Review 3.  Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma.

Authors:  Felix J Hüttner; Christina Fitzmaurice; Guido Schwarzer; Christoph M Seiler; Gerd Antes; Markus W Büchler; Markus K Diener
Journal:  Cochrane Database Syst Rev       Date:  2016-02-16

4.  CRKL protein overexpression enhances cell proliferation and invasion in pancreatic cancer.

Authors:  Lin Fu; Qianze Dong; Chengyao Xie; Yan Wang; Qingchang Li
Journal:  Tumour Biol       Date:  2014-10-16

Review 5.  Pancreatic cancer - a continuing challenge in oncology.

Authors:  Attila Zalatnai
Journal:  Pathol Oncol Res       Date:  2003-12-22       Impact factor: 3.201

6.  Butyrate inhibits pancreatic cancer invasion.

Authors:  Buckminster Farrow; Piotr Rychahou; Kathleen L O'Connor; B Mark Evers
Journal:  J Gastrointest Surg       Date:  2003-11       Impact factor: 3.452

7.  High level of FOXC1 expression is associated with poor prognosis in pancreatic ductal adenocarcinoma.

Authors:  Lei Wang; Feng Gu; Chao-Ying Liu; Run-Jie Wang; Jiang Li; Jun-Ying Xu
Journal:  Tumour Biol       Date:  2012-12-16

8.  CCL20/CCR6 expression profile in pancreatic cancer.

Authors:  Claudia Rubie; Vilma Oliveira Frick; Pirus Ghadjar; Mathias Wagner; Henner Grimm; Benjamin Vicinus; Christoph Justinger; Stefan Graeber; Martin K Schilling
Journal:  J Transl Med       Date:  2010-05-10       Impact factor: 5.531

9.  Pancreatic cancer mortality in China (1991-2000).

Authors:  Li Wang; Gong-Huan Yang; Xing-Hua Lu; Zheng-Jing Huang; Hui Li
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

10.  Anti-inflammatory effects of the Nigella sativa seed extract, thymoquinone, in pancreatic cancer cells.

Authors:  Navdeep Chehl; Galina Chipitsyna; Qiaoke Gong; Charles J Yeo; Hwyda A Arafat
Journal:  HPB (Oxford)       Date:  2009-08       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.